SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.160+6.7%12:31 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael L who wrote (1456)3/27/2001 11:23:04 AM
From: Starlight  Read Replies (1) of 1605
 
Excellent report -

``As a result of our success, the Company's balance sheet as of February 28, 2001 remains strong, highlighted by cash and cash equivalents of $4.7 million, working capital of $12.7 million and no long-term debt. Stockholders' equity improved nearly 81% to $14.4 million from May 31, 2000. In addition, we recently negotiated a $5 million revolving credit line with a bank to provide additional working capital to fund our growth initiatives.''
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News